Glimin MF 3mg/850mg Tablet SR
By Glimin MF
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(3mg) + Metformin(850mg)

Manufacturer - Divine Savior Pvt Ltd
divine savior pvt. ltd. 73, silvar infra hub b/h sakar health care changodar, ta-sanand dist-ahmedabad gujarat, india - 382213

Expires on or after
October, 2025

liver
When using Glimin MF 3mg/850mg Tablet SR, it's important to be cautious if you have liver disease. Patients with liver issues may require dose adjustments, so it's crucial to consult your doctor before taking this medication. Typically, Glimin MF 3mg/850mg Tablet SR is initiated at a low dose for individuals with mild to moderate liver disease. However, it is advisable to avoid using this medication if you have severe liver disease. Remember, always seek guidance from your healthcare provider when considering the use of Glimin MF 3mg/850mg Tablet SR in the presence of liver conditions.

kidney
Caution Glimin MF 3mg/850mg Tablet SR should be used carefully in patients with kidney disease. Dose adjustment may be required, and it is not recommended for severe kidney disease. Regular kidney function tests are advised during treatment. Consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Glimin MF 3mg/850mg Tablet SR. Avoid alcohol consumption for your safety.

driving
When taking Glimin MF 3mg/850mg Tablet SR, avoid driving if experiencing symptoms of low or high blood sugar that may impair your focus or reaction time. It is important to prioritize safety when driving to prevent any risk.

pregnancy
During pregnancy, Glimin MF 3mg/850mg Tablet SR may be unsafe. Animal studies suggest potential harm to the developing baby. Your doctor will evaluate benefits versus risks before prescribing. Consult your doctor for guidance.

breastfeeding
Glimin MF 3mg/850mg Tablet SR is deemed unsafe during breastfeeding, as it may result in toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹70
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025